Close
CDMO Safety Testing 2026
Novotech

CSM To Host A Live Webinar On Direct-To-Patient Shipping For Clinical Trials

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

MSD and Adcendo Initiate Phase Ib Collaboration for Solid Tumours

MSD and Adcendo have established a collaboration and supply...

Decentralized Clinical Trials Market Advances Worldwide

The global Decentralized Clinical Trials Market is expected to...
- Advertisement -

CSM, a leading provider of clinical trial supply services, will conduct an upcoming webinar, “Discover How Direct-to-Patient Shipping is Changing Clinical Trials.”

This webinar, hosted by FierceMarkets, will explore how sponsor companies and CROs are adopting direct-to-patient supply chain strategies to reach and treat patients in new, innovative, and effective ways. This presentation is free to the public and will take place on Wednesday, September 28th, 2:00PM Eastern.ย 

The webinar will cover a comprehensive case study where multiple providers worked together on designing and implementing a direct-to-patient distribution strategy for complex clinical trials. Participants will learn how to strategically design direct-to-patient trials, reach wider patient populations, perform complex clinical trials, and increase patient enrollment and retention rates. Visit this registration page for important information regarding the webinar: http://bit.ly/2b9YuuS .

Moderating the session is Eric Sagonowsky, Associate Editor on the FierceMarkets Life Sciences team. Speaking on the topic of supply chain strategy and logistics planning is Bob Albanese, Senior Vice President of Strategic Development of CSM. Hailee Hunt-Hawkins, Study Coordinator at Vanderbilt Kennedy Center, will discuss the clinical site’s challenges faced as well as patient benefits.ย 

Webinar: Discover How Direct-to-Patient Shipping is Changing Clinical Trialsย 

Speakers:ย 

Bob Albanese, Senior VP of Strategic Development, CSMย 
Hailee Hunt-Hawkins, Study Coordinator, Vanderbilt Kennedy Centerย 

Who Should Attend:ย 

Clinical Operationsย 
Clinical Supply Chain and Logistics
Primary Investigatorsย 
Clinical Trial Coordinatorsย 
Chief Executive Officersย 
Date: Wednesday, September 28, 2016ย 
Time: 2:00PM Easternย 

Register Now: http://bit.ly/2b9YuuS

ย 

World Pharma Today brings together the global pharmaceutical industry โ€” from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives โ€” through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

MSD and Adcendo Initiate Phase Ib Collaboration for Solid Tumours

MSD and Adcendo have established a collaboration and supply...

Decentralized Clinical Trials Market Advances Worldwide

The global Decentralized Clinical Trials Market is expected to...

Quantum Computing Enhancing Clinical Trial Design

The modernization of clinical development is undergoing a massive shift as quantum-based optimization tools are integrated into trial architectures. By improving patient selection and simulating physiological responses at a molecular level, these technologies are reducing the high failure rates associated with traditional research phases. This evolution toward digital and adaptive trials ensures that therapeutic candidates are tested more efficiently, leading to faster regulatory approvals and a more streamlined path for delivering life-saving treatments to the public.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป